Anavex Life Sciences Corp.

US$1.15As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AVXLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (8.46%)
Div yield —
ROE (12.80%)
Biotechnology
Beta (5Y) 1.25
PE TTM —
TSR TTM (85.57%)
Mkt cap US$106.6M
ROIC (10.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.15
0.15%
(79.03%)
Hold 10|11|5|0|6
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.02
0.02
0.02
0.02
17.30%
21.45%
27.78%
25.12%
Revenue$M
6.540
6.567
6.645
6.942
0.82%
0.99%
(1.21%)
3.17%
Peers (US$106.6M)
Cap (US$)
PE
105.7M
—
Capital
TTM
5Y
10Y
Leveragex
1.007
(0.191)
(0.173)
EBIT/Intx
2.212
0.109
0.106
Own earn%
(379.90)
50.48
49.21
Sh yield%
17.97
26.35
26.71
Owners
Insiders/Inst%
14.78
68.99
Short interest%
3.56
SBC / revenue%
1.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
16–20
$1 testx
—
Incr. ROIC%
5